Mannkind (MNKD) Short-term Investments (2010 - 2026)
Mannkind (MNKD) reported Short-term Investments of $81.0 million for Q1 2026, down 39.64% year-over-year from $134.2 million in Q1 2025, and down 16.0% quarter-over-quarter from $96.5 million in Q4 2025.
Mannkind (MNKD) Short-term Investments (2010 - 2026) Analysis & Trends
Mannkind (MNKD) has 13 years of Short-term Investments data on file, last reported at $81.0 million in Q1 2026.
- Short-term Investments for Q1 2026 came in at $81.0 million, down 39.64% year-over-year; the trailing twelve-month figure through Mar 2026 was $81.0 million (down 39.64% YoY), and the FY2025 annual result was $96.5 million, down 36.08% from the prior year.
- Short-term Investments slipped to $81.0 million in Q1 2026 per MNKD's latest filing, from $96.5 million in the prior quarter.
- Over five years, Short-term Investments peaked at $189.2 million in Q3 2024 and troughed at $56.6 million in Q4 2023.
- A 5-year average of $108.5 million and a median of $107.5 million in 2024 frame the typical range for Short-term Investments.
- The sharpest annual moves came in 2022 and 2023: Short-term Investments jumped 228.28% in 2022, then sank 50.98% in 2023.
- A 5-year view of Short-term Investments shows it stood at $101.1 million in 2022, then sank by 43.99% to $56.6 million in 2023, then soared by 166.55% to $150.9 million in 2024, then slumped by 36.08% to $96.5 million in 2025, then declined by 16.0% to $81.0 million in 2026.
- Business Quant data shows MNKD's Short-term Investments at $81.0 million in Q1 2026, $96.5 million in Q4 2025, and $132.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Mannkind | 1.13 Bn | 995.19 Mn | 82.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 81.03 Mn |
| Dec 31, 2025 | 96.46 Mn |
| Sep 30, 2025 | 132.64 Mn |
| Jun 30, 2025 | 121.98 Mn |
| Mar 31, 2025 | 134.23 Mn |
| Dec 31, 2024 | 150.92 Mn |
| Sep 30, 2024 | 189.22 Mn |
| Jun 30, 2024 | 151.12 Mn |
| Mar 31, 2024 | 107.46 Mn |
| Dec 31, 2023 | 56.62 Mn |
| Sep 30, 2023 | 58.00 Mn |
| Jun 30, 2023 | 58.16 Mn |
| Mar 31, 2023 | 80.27 Mn |
| Dec 31, 2022 | 101.08 Mn |
| Sep 30, 2022 | 110.74 Mn |
| Jun 30, 2022 | 118.65 Mn |
| Mar 31, 2022 | 95.20 Mn |
| Dec 31, 2021 | 79.93 Mn |
| Sep 30, 2021 | 87.31 Mn |
| Jun 30, 2021 | 99.97 Mn |